Remove Efficiency Remove Pharmaceuticals Remove Regulations Remove Sourcing
article thumbnail

The Importance of Having a Big Data Strategy for Pharmaceutical Organizations

Infosys Consulting

Improved efficiency: Organizations can improve data quality, minimize duplication, and streamline their data management procedures by establishing a data strategy. Inadequate data governance and security procedures may lead to non-compliance with industry-specific regulations, which could result in penalties and legal repercussions.

article thumbnail

Pharmacokinetics Advancing the Efficiency of Clinical Studies Across Life Sciences Industry

Perficient Digital Transformation

The results of these analyses help pharmaceutical companies better understand the impact drugs can have on the human body and influences critical decisions in the drug manufacturing process. We can proudly stand behind this work, knowing that it could help our partner be more efficient throughout research and development.”.

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mastering healthcare data governance with data lineage

IBM Services

For starters, healthcare organizations constantly encounter vast (and ever-increasing) amounts of highly regulated personal data. Healthcare organizations must adhere to data privacy regulations like HIPAA and GDPR. Issues with compliance and audit conduct also arise due to these scattered data sources.

article thumbnail

6 Ways Intelligent Automation Is Transforming the Pharma Industry

Automation Anywhere

These are just a few of the benefits pharmaceutical, or “pharma,” companies are reaping from deploying intelligent automation. Investment in automation is increasing dramatically today in the pharmaceutical industry. Here are six ways that intelligent automation is helping to transform pharmaceutical companies.

article thumbnail

Decoding the Generative AI Buzz in Life Sciences | Blog

Everest Group

Despite challenges and regulations, the life sciences industry is actively exploring GAI’s possibilities. Although GAI can potentially disrupt the life sciences technology ecosystem in many significant ways, navigating the various risks and challenges that come with its implementation in this highly regulated industry will be critical.

article thumbnail

Five Factors Transforming the Life Sciences Supply Chain and Creating IT Opportunities | Blog

Everest Group

Supply chain visibility, strategic sourcing, cold chain requirements, sustainability demands, and personalized medicine are creating opportunities in the life sciences supply chain for IT partners delivering digital solutions. Read this first part of our blog series to understand the shift that is underway.

article thumbnail

The Hackett Group Announces 2023 Digital Award Winners

The Hackett Group

Plan-to-Source-to-Make-to-Deliver); IBM International Services Centre Slovakia (Order-to-Cash); MTN Group Global Sourcing and Supply Chain (Source-to-Purchase); and Sanofi (Talent Management). Hoffmann-La Roche Ltd. To keep the complexity manageable, DBS Bank decided to build Evolve CloudOps, a unified cloud platform.